CellaVision AB: CellaVision's 2015 Annual Report now available

2016-04-13T08:20:00 CEST - English

Today, CellaVision announced that the company's Annual Report for 2015 is available as PDF at www.cellavision.com, and can be read via the link below.
To request a printed version, please visit the investor pages at CellaVision's website.
For more information, please contact:
Zlatko Rihter, CEO, CellaVision AB
Phone: +46 733 62 11 06 | E-mail: zlatko.rihter@cellavision.com

About CellaVision
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The analyses often constitute important reference data for fast and correct diagnosis of illnesses such as viral and bacterial infections and cancers. CellaVision's products rationalize manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in image analysis, artificial intelligence and automated microscopy. In 2015 sales were SEK 239 million. Sales continue to increase, with a growth target of at least 15 % per year over an economic cycle. CellaVision's head office is in Lund, Sweden and the company has subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq Stockholm, Small Cap list. Read more at www.cellavision.com

PDF version: CellaVision AB Annual report 2015

Subscribe to updates

It's possible to subscribe to CellaVision's press releases, financial information by e-mail and SMS.

Click here to register

Information request

Are you looking for some particular information about our company or our business?

Click here to get in touch


ABG Sundal Collier AB
Victor Forssell
+46 8 566 286 92

Rickard Anderkrans
+46 8 566 286 73

Ulrik Trattner
+46 8 5886 8589

Kristofer Liljeberg
+46 8 5886 87 63

Pareto Securities AB
Christian Lee
+46 84 02 52 67

Johan Unnérus
+46 8 402 52 68


Access our Student Resources

To access this resource, please provide the following information about yourself.